Silence Therapeutics (NASDAQ:SLN), Alnylam Pharmaceuticals (NASDAQ:ALNY), Eli Lilly (NYSE:LLY), Amryt Pharma (NASDAQ:AMYT), SCYNEXIS (NASDAQ:SCYX), SINTX Technologies (NASDAQ:SINT), Ocuphire Pharma (NASDAQ:OCUP), Regeneron Pharmaceuticals (NASDAQ:REGN), VistaGen Therapeutics (NASDAQ:VTGN), Axsome Therapeutics (NASDAQ:AXSM), Lyra Therapeutics (NASDAQ:LYRA), Revance Therapeutics (NASDAQ:RVNC) – Important Biotech Catalysts For September 8, 2022 – End Of The Day Summary
[ad_1] The United States Food and Drug Administration (FDA) has approved Revance Therapeutics’ RVNC lead asset DAXXIFY (DaxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severecfrown lines…
Global Recession Indicator — Or Return To Pre-COVID-19 Demand? Shipping Rates Fall To Near-Pandemic Onset Levels
[ad_1] Consumers had to rethink the way they shopped as a result of COVID-19 lockdowns and the resulting social isolation. Many reconfigured their priorities as well as spent more time online, including shopping, than ever…
Back to school, ECB signals more hikes to come, Powell sticks to hawkish script, Bitcoin hovers around $19k
[ad_1] Parents are rejoicing back to school time and Wall Street is embracing the consistency in the Fed’s messaging that they will keep at it until the job is done…
U.S. dollar rises vs yen as Fed reinforces hawkish stance; euro falls By Reuters
[ad_1] © Reuters. FILE PHOTO: Japanese yen and U.S. dollar banknotes are seen with a currency exchange rate graph in this illustration picture taken June 16, 2022. REUTERS/Florence Lo/Illustration/File Photo/File…
Fedspeak This Week
[ad_1] Federal Reserve – Talking Points Fed Chair Powell reaffirms commitment to fighting inflation on Thursday Recent Fedspeak hints at “higher for longer” approach Recommended by Brendan Fagan Get Your…